Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Different p53 Genotypes Regulate PPARγ Post-Translational Modification in The Adipogenic Differentiation of Cancer Cells
View through CrossRef
Abstract
Background: Our previous studies confirmed that high concentrations of cobalt chloride (CoCl2) can induce the formation of polyploid giant cancer cells (PGCCs). PGCCs have the properties of cancer stem cell. In this study, we demonstrate that PGCCs can be induced to differentiate into adipose in vitro and in vivo. In addition, the molecular mechanism of adipogenic differentiation of PGCCs with daughter cells was investigated by detecting the expression of adipocyte differentiation related proteins in mutant and wild-type p53 cancer cell lines. Methods: HEY and MDA-MB-231 control cells and PGCCs with daughter cells were cultured with adipogenic differentiation medium and the cell cycle was detected by flow cytometry. The expression of adipocyte differentiation related proteins, and P300 histone acetyltransferase activity were compared before and after adipogenic differentiation. Immunoprecipitation was used to analyze the post-translational modification of peroxisome proliferator-activator receptor-γ (PPARγ) and P53 in HEY and MDA-MB-231 control cells and PGCCs with daughter cells cultured with adipogenic differentiation medium. Animal xenograft models were used to study the adipogenic differentiation of PGCCs with daughter cells.Results: Dexamethasone, rosiglitazone, insulin, and 3-isobutyl-1-methylxanthine (IBMX) can force the trans-differentiation of PGCCs into post-mitotic and functional adipocytes. Activation of PPARγ is a critical step in the process of adipogenic differentiation. The expression levels of p-CREBser133, PPARγ, C/EBPα, C/EBPβ were higher in PGCCs with daughter cells after adipogenic differentiation compared with those without adipogenic differentiation in HEY and MDA-MB-231. P53 regulates the acetylation and phosphorylation of PPARγ and the expression of P300- Acetyl-PPARγ(Lys)- FABP4 and ERK- Phospho-PPARγ (Ser112)-FABP4 depended upon the genotype of p53 in HEY and MDA-MB-231 cells after cultured with adipogenic differentiation medium. The invasion and migration abilities of PGCCs with their daughter cells after adipogenic differentiation decreased compared with those cells without adipogenic differentiation.Conclusion: P300-P53-ERK-CREB-PPARγ-CEBPα/β-FABP4 pathway may participate in the adipogenic differentiation of HEY, MDA-MB-231 PGCCs with daughter cells, which associated with genotype of p53.
Springer Science and Business Media LLC
Title: Different p53 Genotypes Regulate PPARγ Post-Translational Modification in The Adipogenic Differentiation of Cancer Cells
Description:
Abstract
Background: Our previous studies confirmed that high concentrations of cobalt chloride (CoCl2) can induce the formation of polyploid giant cancer cells (PGCCs).
PGCCs have the properties of cancer stem cell.
In this study, we demonstrate that PGCCs can be induced to differentiate into adipose in vitro and in vivo.
In addition, the molecular mechanism of adipogenic differentiation of PGCCs with daughter cells was investigated by detecting the expression of adipocyte differentiation related proteins in mutant and wild-type p53 cancer cell lines.
Methods: HEY and MDA-MB-231 control cells and PGCCs with daughter cells were cultured with adipogenic differentiation medium and the cell cycle was detected by flow cytometry.
The expression of adipocyte differentiation related proteins, and P300 histone acetyltransferase activity were compared before and after adipogenic differentiation.
Immunoprecipitation was used to analyze the post-translational modification of peroxisome proliferator-activator receptor-γ (PPARγ) and P53 in HEY and MDA-MB-231 control cells and PGCCs with daughter cells cultured with adipogenic differentiation medium.
Animal xenograft models were used to study the adipogenic differentiation of PGCCs with daughter cells.
Results: Dexamethasone, rosiglitazone, insulin, and 3-isobutyl-1-methylxanthine (IBMX) can force the trans-differentiation of PGCCs into post-mitotic and functional adipocytes.
Activation of PPARγ is a critical step in the process of adipogenic differentiation.
The expression levels of p-CREBser133, PPARγ, C/EBPα, C/EBPβ were higher in PGCCs with daughter cells after adipogenic differentiation compared with those without adipogenic differentiation in HEY and MDA-MB-231.
P53 regulates the acetylation and phosphorylation of PPARγ and the expression of P300- Acetyl-PPARγ(Lys)- FABP4 and ERK- Phospho-PPARγ (Ser112)-FABP4 depended upon the genotype of p53 in HEY and MDA-MB-231 cells after cultured with adipogenic differentiation medium.
The invasion and migration abilities of PGCCs with their daughter cells after adipogenic differentiation decreased compared with those cells without adipogenic differentiation.
Conclusion: P300-P53-ERK-CREB-PPARγ-CEBPα/β-FABP4 pathway may participate in the adipogenic differentiation of HEY, MDA-MB-231 PGCCs with daughter cells, which associated with genotype of p53.
Related Results
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract
Although the main function of p53 is a nuclear transcription factor that has important roles in cell cycle arrest, DNA repair, and apoptosis, p53 can direct...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Abstract 422: Novel approach to destabilization of oncogenic mutant p53 and therapeutic implications
Abstract 422: Novel approach to destabilization of oncogenic mutant p53 and therapeutic implications
Abstract
Introduction: Mutant p53 drives several hallmarks of cancer through a gain-of-function oncogenic program. The oncogenicity of mutant p53 includes sustained ...
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
The AP-1 protein complex primarily consists of several proteins from the c-Fos, c-Jun, activating transcription factor (ATF), and Jun dimerization protein (JDP) families. JDP2 has ...
Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
<p>Supplementary figures (1-12) Supplemental Fig. 1. Normalized levels of monoubiquitinated mutant p53 are shown for indicated cell lines analyzed in Fig. 1a. Supplemental Fi...
Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
<p>Supplementary figures (1-12) Supplemental Fig. 1. Normalized levels of monoubiquitinated mutant p53 are shown for indicated cell lines analyzed in Fig. 1a. Supplemental Fi...